Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 20 and 79 years.
- People who have been on hemodialysis (a kidney filtering treatment) for more than 3 months.
- People who do not currently take part in regular exercise outside of their dialysis sessions.
- People who have not done any exercise during dialysis sessions in the past six months.
- People who do not have any medical reasons that would prevent them from doing physical activity.
- People with a life expectancy of more than 6 months.
- People whose muscles show up clearly enough on ultrasound imaging to allow measurement (confirm with trial site).
Who may not be able to join:
- People who are currently taking part in another interventional clinical trial, or who have done so within the past 3 months.
- People who are still within a restricted period set by a previous clinical trial.
- People who are under legal protection, guardianship, or similar legal arrangements, or who are unable to give informed consent, or who decline to sign a consent form.
- People who are pregnant, recently given birth, or currently breastfeeding.
- People with an unstable heart condition affecting the coronary arteries.
- People with serious circulation problems in the blood vessels of the lower legs (classified as stage III or IV).
- People who have had a limb amputated.
- People with joint, muscle, or bone conditions that make exercise difficult or unsafe.
- People who have a pacemaker, cardiac stimulation device, or an implantable heart device that controls heart rhythm.
- People who have had a heart transplant.
- People with high blood pressure that is not well controlled.
- People with severe anemia (very low red blood cell levels) that has not responded to treatment.
- People considered to be at high risk of blood clots forming in the deep veins.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nans Florens, PhD, CHU Strasbourg
Phone: 0033698050446
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the number of regional wall motion abnormalities (RWMAs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.